Martin C. Clasby

Discovery of Potent Orally Active Thrombin Receptor (Protease Activated Receptor 1) Antagonists as Novel Antithrombotic Agents

Samuel Chackalamannil, Yan Xia, William J. Greenlee et al. · Journal of Medicinal Chemistry · 2005 · 123 citations · Full text

Immunology, Pharmacotherapy, Novel Thrombin Receptor +18

Metabolism-Based Identification of a Potent Thrombin Receptor Antagonist

Martin C. Clasby, Samuel Chackalamannil, Michael Czarniecki et al. · Journal of Medicinal Chemistry · 2006 · 39 citations · Full text

Metabolism-based Identification, Pharmacotherapy, Thrombosis +17

Heterotricyclic Himbacine Analogs as Potent, Orally Active Thrombin Receptor (Protease Activated Receptor-1) Antagonists

Mariappan V. Chelliah, Samuel Chackalamannil, Yan Xia et al. · Journal of Medicinal Chemistry · 2007 · 35 citations · Full text

Combinatorial Chemistry, Robust Inhibition, Pharmacotherapy +19

Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a Protease Inhibitor

Santhosh Neelamkavil, Sony Agrawal, Thomas Bara et al. · ACS Medicinal Chemistry Letters · 2015 · 33 citations · Full text

Ns3/4a Protease Inhibitor, Drug Target, Molecular Biology +17

Progress toward the Synthesis of Sarain A

Clayton H. Heathcock, Martin C. Clasby, David A. Griffith et al. · Synlett · 1995 · 32 citations

Sarain A, Diversity Oriented Synthesis, Scheme 1 +9